Publications

Hellingman A, Göttle N.L, Walz A, Brancucci N.M.B, Wittlin S, Mäser P, Rottmann M. Using next generation chemiluminescent probes to improve the Plasmodium falciparum in vitro parasite reduction ratio (PRR) assay. ACS Infect Dis. 2026(in press). DOI: 10.1021/acsinfecdis.5c00924

Hellingman A, Sifoniou K, Buser T, Thommen B.T, Walz A, Passecker A, Collins J, Hupfeld M, Wittlin S, Witmer K, Brancucci N.M.B. Next generation chemiluminescent probes for antimalarial drug discovery. ACS Infect Dis. 2024;10(4):1286−1297. DOI: 10.1021/acsinfecdis.3c00707

Hellingman A. Testing the new generation chemiluminescent probe “AquaSparkTM beta-D-galactoside” for a novel in vitro method to evaluate antimalarial activity. Allschwil/Basel: Swiss Tropical and Public Health Institute, 2023. MSc Thesis